What is the market doing?
What the tape says about ZTS
Zoetis is −46% over the past year while the S&P 500 is +23%: 69 points behind the market. Through the fall, its own insiders bought $886K more stock than they sold.
−46%
1-year return · S&P 500 +23%
- vs 200-day average
- −28%
vs 200-day average · a clear downtrend
- RSI (14)
- 51
RSI (14) · neutral
- Below its 52-week high
- −50%
Below its 52-week high
Details›
- Last close2026-08-26
- $77.53
- 1 monthS&P 500 +3.7%
- +4.0%
- 1 yearS&P 500 +23%
- −46%
- 5 yearsS&P 500 +87%
- −60%
- vs 50-day average$76.74
- +1.0%
- 52-week high
- $154.88
- 52-week low
- $72.63
- Annualised volatility
- 32%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $886K
| Year | Return |
|---|---|
| 2026 (year to date) | −38% |
| 2025 | −22% |
| 2024 | −17% |
| 2023 | +36% |
| 2022 | −40% |
| 2021 | +48% |
| 2020 | +26% |
| 2019 | +56% |
| 2018 | +19% |
| 2017 | +36% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +0.07% |
| Feb | 10 | 6 of 10 | +1.8% |
| Mar | 10 | 4 of 10 | −2.9% |
| Apr | 10 | 6 of 10 | +1.4% |
| May | 10 | 6 of 10 | −0.86% |
| Jun | 10 | 8 of 10 | +2.0% |
| Jul | 11 | 9 of 11 | +3.8% |
| Aug | 11 | 10 of 11 | +1.7% |
| Sep | 10 | 5 of 10 | −1.3% |
| Oct | 10 | 4 of 10 | −1.6% |
| Nov | 10 | 7 of 10 | +2.3% |
| Dec | 10 | 5 of 10 | +1.8% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #5 of 28 by Smart Score